Home » Topics » BioWorld Science

BioWorld Science
RSS

Biomet and Merck KGaA to form joint venture

May 21, 1997

DepoMed seeks alliances for drug delivery systems

May 21, 1997

Chiroscience starts clinical development of PDE IV inhibitor

May 21, 1997

VIMRx acquires worldwide rights to wound-healing agent

May 21, 1997

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Gensia receives ANDA approval for etoposide injection

May 21, 1997

Leukotriene biosynthesis inhibitors from Abbott

May 21, 1997

Excitatory amino acid antagonists disclosed by Glaxo Wellcome

May 21, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.